PTPI Historical PE Ratio image   This PTPI PE ratio history page last updated 12/7/2022
PTPI PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/15/2022
4.90-6.70-7.70NA
Q2 2022
8/15/2022
8.05-0.90-8.50NA
Q1 2022
5/16/2022
9.50-0.10-9.30NA
Q4 2021
4/1/2022
14.60-7.50NANA
Q3 2021
11/15/2021
21.80-1.70NANA
Q2 2021
8/16/2021
27.10-2.20NANA
PTPI Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/15/2022
4.90-6.70-26.80NA
Q2 2022
8/15/2022
8.05-0.90-3.60NA
Q1 2022
5/16/2022
9.50-0.10-0.40NA
Q4 2021
4/1/2022
14.60-7.50-30.00NA
Q3 2021
11/15/2021
21.80-1.70-6.80NA
Q2 2021
8/16/2021
27.10-2.20-8.80NA
Quotes delayed 20 minutes

Email EnvelopeFree PTPI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Petros Pharmaceuticals (PTPI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PULM PE Ratio History
QDEL PE Ratio History
QLGN PE Ratio History
QNCX PE Ratio History
QTRX PE Ratio History
RAIN PE Ratio History
RANI PE Ratio History
RAPT PE Ratio History
RARE PE Ratio History
RCEL PE Ratio History
On this page we presented the PTPI PE Ratio History information for Petros Pharmaceuticals' stock. The average PTPI PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PTPI PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PTPI PE ratio history result, against the recent PE: when this page was posted on 12/6/2022, the most recent closing price for PTPI had been 3.20, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on PTPI or any other given stock, valuation analysis for PTPI can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Petros Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for PTPI. Thanks for visiting, and the next time you need to research PTPI PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: HST Technical Analysis, APE Historical Stock Prices, AEP Dividend History.

 

PTPI PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.